These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 30922965)

  • 1. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
    Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
    EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer.
    Guo Z; Peng G; Li E; Xi S; Zhang Y; Li Y; Lin X; Li G; Wu Q; He J
    Sci Rep; 2017 Sep; 7(1):10612. PubMed ID: 28878291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
    Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
    Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways.
    Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z
    Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Wang K; Chen B; Yin T; Zhan Y; Lu Y; Zhang Y; Chen J; Wu W; Zhou S; Mao W; Tan Y; Du B; Liu X; Ho HI; Xiao J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
    Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
    J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
    Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
    Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways.
    Shan F; Shao Z; Jiang S; Cheng Z
    Cancer Med; 2016 Nov; 5(11):3166-3175. PubMed ID: 27726288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
    Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phanginin R Induces Cytoprotective Autophagy via JNK/c-Jun Signaling Pathway in Non-Small Cell Lung Cancer A549 Cells.
    Zhang LL; Bao H; Xu YL; Jiang XM; Li W; Zou L; Lin LG; Lu JJ
    Anticancer Agents Med Chem; 2020; 20(8):982-988. PubMed ID: 32286950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.
    Liu X; Li C; Yang Y; Liu X; Li R; Zhang M; Yin Y; Qu Y
    EBioMedicine; 2019 Aug; 46():42-53. PubMed ID: 31395502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.
    Qian Y; Pei D; Cheng T; Wu C; Pu X; Chen X; Liu Y; Shen H; Zhang W; Shu Y
    Med Oncol; 2015 Mar; 32(3):44. PubMed ID: 25631633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
    Xin T; Lv W; Liu D; Jing Y; Hu F
    Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
    Chen L; Han X; Hu Z; Chen L
    Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
    Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
    Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.